FdaApplication
ANDA 064200
Identifiers
- fda_app_no: ANDA064200
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2000-03-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEFOTAXIME | CEFOTAXIME SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION |
| CEFOTAXIME | CEFOTAXIME SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
| CEFOTAXIME | CEFOTAXIME SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION |
3 products